首页> 美国卫生研究院文献>The Pan African Medical Journal >Rectal stromal tumor with an exceptional liver and bone metastatic locations
【2h】

Rectal stromal tumor with an exceptional liver and bone metastatic locations

机译:直肠间质肿瘤肝脏和骨转移部位异常

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gastrointestinal stromal tumours (GIST) are rare mesenchymal tumours which represent 1% to 3% of gastrointestinal neoplasm. Rectal location of GIST is extremely rare reaching 5% of GIST and only 0.1% of rectal tumours. They usually metastases to the liver (65%) and exceptionally to the bone (3%). We reported a case of rectal stromal tumour with an exceptional metastasis located in the rib. A 40-year-old man who presented with pelvic pain, associated with rectal syndrome, rectal bleeding and subocclusive episodes. Physical examination objectified a tough, budding rectal mass, with a smooth wall, localized 3cm above of anal margin. A Thoraco-abdominal computed tomography showed a large heterogeneous tissue mass, taking the whole pelvis, coming from the right-side wall of the rectum of 17.3 x 14cm. It was associated with liver and bone secondary locations. Biopsies confirmed the secondary locations of an intermediate risk GIST. Immunohistochemical study showed an overexpression of c-kit protein (CD117) and Dog1. Imatinib was prescribed to reduce the tumour size. Stromal metastatic rectal tumours in bone level are extremely rare conditions. The diagnosis is confirmed by histological examination with immune histochemical analysis. The prognosis remains poor in metastatic forms but it has been improved since the introduction of Imatinib.
机译:胃肠道间质瘤(GIST)是罕见的间质肿瘤,占胃肠道肿瘤的1%至3%。 GIST的直肠位置极为罕见,达到GIST的5%,仅占直肠肿瘤的0.1%。它们通常转移到肝脏(65%),另外转移到骨骼(3%)。我们报道了一例直肠间质瘤,其位于肋骨处有异常转移。一名40岁男子,出现骨盆疼痛,伴有直肠综合征,直肠出血和闭塞性发作。体格检查的目标是坚硬,发芽的直肠肿块,壁光滑,位于肛门边缘上方3cm处。胸腹计算机断层扫描显示较大的异质组织肿块,整个骨盆取自直肠的右侧壁17.3 x 14cm。它与肝脏和骨骼的次要位置有关。活检证实了中等风险GIST的次要位置。免疫组织化学研究显示c-kit蛋白(CD117)和Dog1过表达。开了伊马替尼以减少肿瘤大小。骨水平间质转移性直肠肿瘤是极为罕见的疾病。通过免疫组织化学分析的组织学检查证实了诊断。转移形式的预后仍然很差,但是自从伊马替尼引入以来,预后得到了改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号